{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T22:59:37Z","timestamp":1792623577919,"version":"4.5.0"},"reference-count":37,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,7]]},"DOI":"10.1097\/fjc.0b013e3181ac3a34","type":"journal-article","created":{"date-parts":[[2009,7,15]],"date-time":"2009-07-15T07:31:32Z","timestamp":1247643092000},"page":"72-81","source":"Crossref","is-referenced-by-count":44,"title":["TRC4186, a Novel AGE-breaker, Improves Diabetic Cardiomyopathy and Nephropathy in Ob-ZSF1 Model of Type 2 Diabetes"],"prefix":"10.1097","volume":"54","author":[{"given":"Deepa","family":"Joshi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ram","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amita","family":"Dubey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ajay","family":"Shiwalkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Padmaja","family":"Pathak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramesh C","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vijay","family":"Chauthaiwale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chaitanya","family":"Dutt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-11-20210208","doi-asserted-by":"crossref","first-page":"11704","DOI":"10.1073\/pnas.91.24.11704","article-title":"Advanced glycation end products induce glomerular sclerosis and albuminuria in normal rats.","volume":"91","author":"Vlassara","year":"1994","journal-title":"Proc Natl Acad Sci USA"},{"key":"R2-11-20210208","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1007\/s001250051198","article-title":"Suppression of transforming growth factor beta and vascular endothelial growth factor in diabetic nephropathy in rats by a novel advanced glycation end product inhibitor, OPB-9195.","volume":"42","author":"Tsuchida","year":"1999","journal-title":"Diabetologia"},{"key":"R3-11-20210208","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0026-0495(85)80008-1","article-title":"Protein glycosylation and the pathogenesis of atherosclerosis.","volume":"34","author":"Cerami","year":"1985","journal-title":"Metabolism"},{"key":"R4-11-20210208","doi-asserted-by":"crossref","first-page":"6434","DOI":"10.1073\/pnas.90.14.6434","article-title":"Lipid advanced glycosylation: pathway for lipid oxidation in vivo.","volume":"90","author":"Bucala","year":"1993","journal-title":"Proc Natl Acad Sci USA"},{"key":"R5-11-20210208","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1161\/01.RES.0000065620.39919.20","article-title":"A breaker of advanced glycation end products attenuates diabetes-induced myocardial structural changes.","volume":"92","author":"Candido","year":"2003","journal-title":"Circ Res"},{"key":"R6-11-20210208","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1007\/BF03401860","article-title":"Advanced glycation endproducts: activators of cardiac remodeling in primary fibroblasts from adult rat hearts.","volume":"7","author":"Daoud","year":"2001","journal-title":"Mol Med"},{"key":"R7-11-20210208","doi-asserted-by":"crossref","first-page":"463","DOI":"10.2337\/diabetes.53.2.463","article-title":"Diabetes increases formation of advanced glycation end products on sarco(endo)plasmic reticulum Ca2-ATPase.","volume":"53","author":"Bidasee","year":"2004","journal-title":"Diabetes"},{"key":"R8-11-20210208","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.2337\/diabetes.49.9.1561","article-title":"Endothelin 1 transcription is controlled by nuclear factor-kappaB in AGE-stimulated cultured endothelial cells.","volume":"49","author":"Quehenberger","year":"2000","journal-title":"Diabetes"},{"key":"R9-11-20210208","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1177\/026765910001500203","article-title":"The role of nitric oxide synthase\/nitric oxide in vascular smooth muscle control.","volume":"15","author":"Sanders","year":"2000","journal-title":"Perfusion"},{"key":"R10-11-20210208","first-page":"388","article-title":"TRC4149 a novel advanced glycation end product breaker improves hemodynamics status in diabetic spontaneously hypertensive rats.","volume":"13","author":"Pathak","year":"2008","journal-title":"Eur J Med Res"},{"key":"R12-11-20210208","first-page":"257","article-title":"Committee for the Purpose of Control and Supervision on Experiments on Animals.","volume":"35","year":"2003","journal-title":"Ind J Pharmacol"},{"key":"R14-11-20210208","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1081\/JDI-100100882","article-title":"Renal function and structure in diabetic, hypertensive, obese ZDFxSHHF-hybrid rats.","volume":"22","author":"Tofovic","year":"2000","journal-title":"Ren Fail"},{"key":"R15-11-20210208","first-page":"29","article-title":"Rat model of metabolic syndrome.","volume":"86","author":"Tofovic","year":"2003","journal-title":"Methods Mol Med"},{"key":"R16-11-20210208","doi-asserted-by":"crossref","first-page":"2879","DOI":"10.1093\/eurheartj\/ehm486","article-title":"Clinical and prognostic value of advanced glycation end-products in chronic heart failure.","volume":"28","author":"Hartog","year":"2007","journal-title":"Eur Heart J"},{"key":"R17-11-20210208","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.cardiores.2007.06.022","article-title":"Functional, structural and molecular aspects of diastolic heart failure in the diabetic (mRen-2)27 rat.","volume":"76","author":"Connelly","year":"2007","journal-title":"Cardiovasc Res"},{"key":"R18-11-20210208","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.ejheart.2006.05.014","article-title":"Systolic and diastolic heart failure: different phenotypes of the same disease?","volume":"9","author":"De Keulenaer","year":"2007","journal-title":"Eur J Heart Fail"},{"key":"R19-11-20210208","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1006\/phrs.1998.0290","article-title":"Changes in diastolic function and hypertensive rats with long-term streptozotocin-induced diabetes.","volume":"37","author":"Riva","year":"1998","journal-title":"Pharmacol Res"},{"key":"R20-11-20210208","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1475-2840-5-7","article-title":"Cardiac dysfunction in the diabetic rat: quantitative evaluation using high resolution magnetic resonance imaging.","volume":"5","author":"Loganathan","year":"2006","journal-title":"Cardiovasc Diabetol"},{"key":"R21-11-20210208","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1253\/circj.70.327","article-title":"Left ventricular dysfunction and remodeling in streptozotocin-induced diabetic rats.","volume":"70","author":"Nemoto","year":"2006","journal-title":"Circ J"},{"key":"R22-11-20210208","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/1475-2840-6-30","article-title":"Effect of streptozotocin-induced diabetes on left ventricular function in adult rats: an in vivo Pinhole Gated SPECT study.","volume":"6","author":"Cosyns","year":"2007","journal-title":"Cardiovasc Diabetol"},{"key":"R23-11-20210208","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S1054-8807(03)00109-1","article-title":"Myocardial hypertrophy and enhanced left ventricular contractility in Zucker diabetic fatty rats.","volume":"13","author":"Fredersdorf","year":"2004","journal-title":"Cardiovasc Pathol"},{"key":"R24-11-20210208","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1007\/s00395-007-0673-0","article-title":"Tumor necrosis factor-alpha antagonism protects from myocardial inflammation and fibrosis in experimental diabetic cardiomyopathy.","volume":"102","author":"Westermann","year":"2007","journal-title":"Basic Res Cardiol"},{"key":"R25-11-20210208","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.jtcvs.2006.12.059","article-title":"Diabetes increases apoptosis and necrosis in both ischemic and non-ischemic human myocardium: Role of caspases and poly-adenosine diphosphate-ribose polymerase.","volume":"134","author":"Chowdhry","year":"2007","journal-title":"J Thorac Cardiovasc Surg"},{"key":"R26-11-20210208","doi-asserted-by":"crossref","first-page":"R795","DOI":"10.1152\/ajpregu.2001.281.3.R795","article-title":"Hyperglycemia modulates angiotensinogen gene expression.","volume":"281","author":"Gabriely","year":"2001","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"R27-11-20210208","doi-asserted-by":"crossref","first-page":"2975","DOI":"10.1210\/endo.143.8.8931","article-title":"High glucose stimulates angiotensinogen gene expression via reactive oxygen species generation in rat kidney proximal tubular cells.","volume":"143","author":"Hsieh","year":"2002","journal-title":"Endocrinology"},{"key":"R28-11-20210208","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1681\/ASN.V1081778","article-title":"Impact of hyperglycemia on the renin angiotensin system in early human type 1 diabetes mellitus.","volume":"10","author":"Miller","year":"1999","journal-title":"J Am Soc Nephrol"},{"key":"R29-11-20210208","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.pharmthera.2005.10.008","article-title":"Vascular endothelial dysfunction in diabetic cardiomyopathy: Pathogenesis and potential treatment targets.","volume":"111","author":"Farhangkhoee","year":"2006","journal-title":"Pharmacol Ther"},{"key":"R30-11-20210208","doi-asserted-by":"crossref","first-page":"3377","DOI":"10.1161\/01.CIR.92.12.3377","article-title":"Diagnostic significance of impaired lv systolic relaxation in heart failure.","volume":"92","author":"Sys","year":"1995","journal-title":"Circulation"},{"key":"R31-11-20210208","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.2337\/diab.40.10.1328","article-title":"Retardation by aminoguanidine of development of albuminuria, mesangial expansion, and tissue fluorescence in streptozocin-induced diabetic rat.","volume":"40","author":"Soulis-Liparota","year":"1991","journal-title":"Diabetes"},{"key":"R32-11-20210208","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1016\/j.ejheart.2007.05.010","article-title":"Decreased cardiac output, venous congestion and the association with renal impairment in patients with cardiac dysfunction.","volume":"9","author":"Damman","year":"2007","journal-title":"Eur J Heart Fail"},{"key":"R33-11-20210208","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1161\/01.CIR.93.10.1905","article-title":"Aminoguanidine prevents the decreased myocardial compliance produced by streptozotocin-induced diabetes mellitus in rats.","volume":"93","author":"Norton","year":"1996","journal-title":"Circulation"},{"key":"R34-11-20210208","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/0272-6386(95)90051-9","article-title":"Advanced glycosylation end products in diabetic renal and vascular disease.","volume":"26","author":"Bucala","year":"1995","journal-title":"Am J Kidney Dis"},{"key":"R35-11-20210208","doi-asserted-by":"crossref","first-page":"4630","DOI":"10.1073\/pnas.95.8.4630","article-title":"Breakers of advanced glycation end products restore large artery properties in experimental diabetes.","volume":"95","author":"Wolffenbuttel","year":"1998","journal-title":"Proc Natl Acad Sci USA"},{"key":"R36-11-20210208","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1161\/01.RES.0000065620.39919.20","article-title":"A breaker of advanced glycation end products attenuates diabetes-induced myocardial structural changes.","volume":"92","author":"Candido","year":"2003","journal-title":"Circ Res"},{"key":"R37-11-20210208","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1159\/000095786","article-title":"Prevention and reversal of diabetic nephropathy in db\/db mice treated with alagebrium (ALT-711).","volume":"26","author":"Peppa","year":"2006","journal-title":"Am J Nephrol"},{"key":"R38-11-20210208","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1097\/HJH.0b013e328013e7dd","article-title":"Advanced glycation endproduct crosslink breaker (alagebrium) improves endothelial function in patients with isolated systolic hypertension.","volume":"25","author":"Zieman","year":"2007","journal-title":"J Hypertens"},{"key":"R39-11-20210208","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.cardfail.2004.09.010","article-title":"The effect of alagebrium chloride (ALT-711), a novel glucose cross-link breaker, in the treatment of elderly patients with diastolic heart failure.","volume":"11","author":"Little","year":"2005","journal-title":"J Card Fail"}],"container-title":["Journal of Cardiovascular Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.lww.com\/00005344-200907000-00011","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,8]],"date-time":"2021-10-08T17:25:52Z","timestamp":1633713952000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00005344-200907000-00011"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,7]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009]]}},"URL":"https:\/\/doi.org\/10.1097\/fjc.0b013e3181ac3a34","relation":{},"ISSN":["0160-2446"],"issn-type":[{"value":"0160-2446","type":"print"}],"subject":[],"published":{"date-parts":[[2009,7]]}}}